Who does this study affect: People with untreated, advanced non-small cell lung cancer (NSCLC). What did this study find: Results from the phase III CHOICE-01 clinical trial in China show that adding the immunotherapy drug toripalimab (TuoYi) to chemotherapy in people with untreated, advanced NSCLC slowed cancer growth and helped them live longer, particularly if […]

My normal morning suddenly became life-changing for me. I found a lump in my left breast and noticed that I also had a nipple retraction. I called my sister, Sharon, and told her that I believed I may have breast cancer. Later at work, I used my lunch break to go to see my doctor, […]

Who does this study affect: People with untreated advanced melanoma What did this study find: What did this study find: A new report from the global phase II/III RELATIVITY-047 clinical trialshows that a combination of the immunotherapy drugs relatlimab and nivolumab (Opdivo) remains effective in slowing the growth of untreated advanced melanoma. The combination treatment […]

It’s tempting to want to avoid talking about addressing problems. Yet not talking about a problem will not make it go away. In general, it’s much better to actively address the problem. Here’s the difference: Active Ways to Cope Take action to get rid of the problem Plan how to deal with the problem Look […]